# Dr.Cuiyutao Healthcare Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dr-cuiyutao-healthcare-co

- Industry: Healthcare
- Headquarters: Beijing, China
- Website: www.ivybaby.me
- Total disclosed funding: $30M
- Latest round: Series C (Jan 13, 2017)
- Investors on record: 4

## About

Dr.Cuiyutao Healthcare Co., Ltd. specializes in providing comprehensive parenting solutions, focusing on the early stages of child-rearing through technological innovation and expert resources.Founded in 2014 and headquartered in Beijing, China, Dr.Cuiyutao Healthcare Co., Ltd. develops tools and services for new parents. The company has successfully completed four deals, with the latest being a Series C round on February 6, 2018, where it raised USD 20.00 mn led by Jiyuan Capital, with participation from HighLight Capital and Wu Capital. The company is headed by CEO Zongzong Shao.Dr.Cuiyutao Healthcare Co., Ltd. offers??? (Yuxueyuan), a mobile application that acts as a portable parenting guide. It includes resources like parenting tips, expert video programs, and curated educational content. The app features '?????' (Medical Insights Made Clear), delivering succinct answers to common parental concerns. Additionally, the company operates a media platform that shares reliable maternal and infant health information, targeting new parents, especially urban mothers in China.The company's revenue model leverages direct-to-consumer transactions through its app and partnerships with health professionals. Users access premium content and personalized parenting support via subscription services. Collaborations with healthcare providers and educational institutions for workshops and seminars further enhance offerings and generate revenue, positioning the company as a resourceful entity in maternal and child health.Dr.Cuiyutao Healthcare Co., Ltd. plans to expand its product range and enhance user experience with new features in??? (Yuxueyuan) by the end of 2023. The company aims to penetrate additional urban markets in China and possibly explore international markets by 2024. Recent funding from the Series C round will facilitate these innovations and support market expansion efforts.

## Funding rounds

- Series C, Jan 13, 2017, $20M — Wu Capital, HighLight Capital, Jiyuan Capital
- Series B, Jan 7, 2016, $10M — HighLight Capital, Beijing Shuanghu Investment Management
- Series A, Feb 5, 2015 — HighLight Capital

## Investors

- HighLight Capital (https://capitalatlas.ai/funds/highlight-capital) — Series A, Series B, Series C
- Beijing Shuanghu Investment Management — Series B
- Wu Capital — Series C
- Jiyuan Capital (https://capitalatlas.ai/funds/jiyuan-capital) — Series C